| Product Code: ETC9945661 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Haemophilia Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Haemophilia Market - Industry Life Cycle |
3.4 United Kingdom (UK) Haemophilia Market - Porter's Five Forces |
3.5 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.9 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 United Kingdom (UK) Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in treatment options for haemophilia |
4.2.2 Increasing awareness and diagnosis rates of haemophilia in the UK |
4.2.3 Growing research and development activities in the field of haemophilia treatments |
4.3 Market Restraints |
4.3.1 High cost associated with haemophilia treatment and management |
4.3.2 Limited access to specialized healthcare services in certain regions of the UK |
4.3.3 Regulatory challenges and compliance requirements in the haemophilia market |
5 United Kingdom (UK) Haemophilia Market Trends |
6 United Kingdom (UK) Haemophilia Market, By Types |
6.1 United Kingdom (UK) Haemophilia Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Desmopressin, 2021- 2031F |
6.1.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Emicizumab, 2021- 2031F |
6.1.6 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Anti-fibrinolytics, 2021- 2031F |
6.1.7 United Kingdom (UK) Haemophilia Market Revenues & Volume, By ITI Therapy, 2021- 2031F |
6.1.8 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.9 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Haemophilia Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Haemophilia Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.3.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Genetic Tests, 2021- 2031F |
6.3.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Haemophilia Market, By Patient |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Adult, 2021- 2031F |
6.5 United Kingdom (UK) Haemophilia Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia A, 2021- 2031F |
6.5.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia B, 2021- 2031F |
6.5.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Haemophilia C, 2021- 2031F |
6.5.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Haemophilia Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7 United Kingdom (UK) Haemophilia Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United Kingdom (UK) Haemophilia Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Haemophilia Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Haemophilia Market Export to Major Countries |
7.2 United Kingdom (UK) Haemophilia Market Imports from Major Countries |
8 United Kingdom (UK) Haemophilia Market Key Performance Indicators |
8.1 Patient adherence and compliance rates to prescribed haemophilia treatment plans |
8.2 Number of clinical trials and research studies conducted in the field of haemophilia in the UK |
8.3 Rate of adoption of new haemophilia treatment technologies and therapies in the UK market |
9 United Kingdom (UK) Haemophilia Market - Opportunity Assessment |
9.1 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
9.5 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 United Kingdom (UK) Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Haemophilia Market - Competitive Landscape |
10.1 United Kingdom (UK) Haemophilia Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here